These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7990108)

  • 1. Novel antiproliferative agents derived from lavendustin A.
    Nussbaumer P; Winiski AP; Cammisuli S; Hiestand P; Weckbecker G; Stütz A
    J Med Chem; 1994 Nov; 37(24):4079-84. PubMed ID: 7990108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of a series of lavendustin A analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization.
    Mu F; Coffing SL; Riese DJ; Geahlen RL; Verdier-Pinard P; Hamel TE; Johnson J; Cushman M
    J Med Chem; 2001 Feb; 44(3):441-52. PubMed ID: 11462983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors.
    Smyth MS; Stefanova I; Hartmann F; Horak ID; Osherov N; Levitzki A; Burke TR
    J Med Chem; 1993 Oct; 36(20):3010-4. PubMed ID: 8105084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by two lavendustins of the tyrosine kinase activity of pp60F527 in vitro and in intact cells.
    Agbotounou WK; Umezawa K; Jacquemin-Sablon A; Pierre J
    Eur J Pharmacol; 1994 Sep; 269(1):1-8. PubMed ID: 7828651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies on a novel class of antiproliferative agents derived from Lavendustin A. Part I: Ring A modifications.
    Nussbaumer P; Winiski AP
    Bioorg Med Chem; 2008 Aug; 16(16):7552-60. PubMed ID: 18678497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDZ 281-977: a modified partial structure of lavendustin A that exerts potent and selective antiproliferative activities in vitro and in vivo.
    Cammisuli S; Winiski A; Nussbaumer P; Hiestand P; Stütz A; Weckbecker G
    Int J Cancer; 1996 Jan; 65(3):351-9. PubMed ID: 8575857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.
    Traxler P; Trinks U; Buchdunger E; Mett H; Meyer T; Müller M; Regenass U; Rösel J; Lydon N
    J Med Chem; 1995 Jun; 38(13):2441-8. PubMed ID: 7608909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase.
    El-Zarruk AA; van den Berg HW
    Cancer Lett; 1999 Aug; 142(2):185-93. PubMed ID: 10463775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue.
    Hsu CY; Persons PE; Spada AP; Bednar RA; Levitzki A; Zilberstein A
    J Biol Chem; 1991 Nov; 266(31):21105-12. PubMed ID: 1939153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase.
    Traxler PM; Wacker O; Bach HL; Geissler JF; Kump W; Meyer T; Regenass U; Roesel JL; Lydon N
    J Med Chem; 1991 Aug; 34(8):2328-37. PubMed ID: 1652014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tyrosine kinase and epidermal growth factor receptor internalization by lavendustin A methyl ester in cultured A431 cells.
    Onoda T; Isshiki K; Takeuchi T; Tatsuta K; Umezawa K
    Drugs Exp Clin Res; 1990; 16(6):249-53. PubMed ID: 2086161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Anilinoquinazolines with Lavendustin A subunit as inhibitors of epidermal growth factor receptor tyrosine kinase: syntheses, chemical and pharmacological properties.
    Albuschat R; Löwe W; Weber M; Luger P; Jendrossek V
    Eur J Med Chem; 2004 Dec; 39(12):1001-11. PubMed ID: 15571862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticancer activity of chromone-based analogs of lavendustin A.
    Nam DH; Lee KY; Moon CS; Lee YS
    Eur J Med Chem; 2010 Sep; 45(9):4288-92. PubMed ID: 20630626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.
    Onoda T; Iinuma H; Sasaki Y; Hamada M; Isshiki K; Naganawa H; Takeuchi T; Tatsuta K; Umezawa K
    J Nat Prod; 1989; 52(6):1252-7. PubMed ID: 2614420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of substituted 3-[(4,5,6, 7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rbeta tyrosine kinases.
    Sun L; Tran N; Liang C; Hubbard S; Tang F; Lipson K; Schreck R; Zhou Y; McMahon G; Tang C
    J Med Chem; 2000 Jul; 43(14):2655-63. PubMed ID: 10893303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors.
    Yaish P; Gazit A; Gilon C; Levitzki A
    Science; 1988 Nov; 242(4880):933-5. PubMed ID: 3263702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases.
    Palmer BD; Rewcastle GW; Thompson AM; Boyd M; Showalter HD; Sercel AD; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1995 Jan; 38(1):58-67. PubMed ID: 7837241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
    Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.